These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11592807)

  • 21. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
    Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
    Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of familial combined hyperlipidemia.
    Pajukanta P; Porkka KV
    Curr Atheroscler Rep; 1999 Jul; 1(1):79-86. PubMed ID: 11122695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abdominal obesity and expression of familial combined hyperlipidemia.
    van der Kallen CJ; Voors-Pette C; de Bruin TW
    Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
    Lee JC; Lusis AJ; Pajukanta P
    Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
    Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA
    Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.
    Coon H; Singh N; Dunn D; Eckfeldt JH; Province MA; Hopkins PN; Weiss R; Hunt SC; Leppert MF;
    Atherosclerosis; 2004 Jun; 174(2):357-62. PubMed ID: 15136067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
    Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
    Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan.
    Badzioch MD; Igo RP; Gagnon F; Brunzell JD; Krauss RM; Motulsky AG; Wijsman EM; Jarvik GP
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1942-50. PubMed ID: 15331429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.
    Aouizerat BE; Allayee H; Cantor RM; Davis RC; Lanning CD; Wen PZ; Dallinga-Thie GM; de Bruin TW; Rotter JI; Lusis AJ
    Am J Hum Genet; 1999 Aug; 65(2):397-412. PubMed ID: 10417282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
    Pajukanta P; Porkka KV; Antikainen M; Taskinen MR; Perola M; Murtomäki-Repo S; Ehnholm S; Nuotio I; Suurinkeroinen L; Lahdenkari AT; Syvänen AC; Viikari JS; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):841-50. PubMed ID: 9157946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The level and species of plasma non-esterified fatty acids are not related to elevated plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Shamir R; Williams KJ; Cortner JL; Hudgins LC; Levine LC; McGee-Harper M; Fisher EA
    J Med; 2001; 32(5-6):349-63. PubMed ID: 11958280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia.
    Solanas-Barca M; de Castro-Orós I; Mateo-Gallego R; Cofán M; Plana N; Puzo J; Burillo E; Martín-Fuentes P; Ros E; Masana L; Pocoví M; Civeira F; Cenarro A
    Atherosclerosis; 2012 Jun; 222(2):449-55. PubMed ID: 22481068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.
    Brouwers MC; Govers-Riemslag J; Schalkwijk CG; van Greevenbroek MM; van der Kallen CJ; Bekers O; van Dieijen-Visser MP; Ten Oever J; Bilderbeek-Beckers MA; de Bruin TW; Ten Cate H; Stehouwer CD
    Thromb Res; 2008; 122(4):466-72. PubMed ID: 18262228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel genes for familial combined hyperlipidemia.
    Aouizerat BE; Allayee H; Bodnar J; Krass KL; Peltonen L; de Bruin TW; Rotter JI; Lusis AJ
    Curr Opin Lipidol; 1999 Apr; 10(2):113-22. PubMed ID: 10327279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
    Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
    Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.